Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Utah Medical Products raises dividend to 30 cents a share

EditorRachael Rajan
Published 02/06/2024, 10:48 AM
Updated 02/06/2024, 10:48 AM
© Reuters.

SALT LAKE CITY - Utah Medical Products, Inc. (NASDAQ:UTMD), a global provider of medical devices, has declared a quarterly cash dividend of thirty cents ($.30) per share, an increase from the dividend issued in the corresponding quarter of the previous year. The dividend is scheduled for payment on April 3, 2024, to shareholders of record as of the close of business on March 15, 2024.

This announcement marks a 1.7% rise from the dividend declared in the same quarter last year.

Utah Medical Products specializes in healthcare products for women and their babies, developing and marketing a wide array of disposable and reusable specialty medical devices.

This news is based on a press release statement from Utah Medical Products, Inc.

InvestingPro Insights

Utah Medical Products, Inc. (NASDAQ:UTMD) has shown a consistent approach to returning value to its shareholders, as evidenced by the recent dividend increase. Amidst the market dynamics, UTMD's commitment to maintaining dividend payments over an impressive span of two decades stands out. According to InvestingPro Tips, the company has maintained dividend payments for 20 consecutive years, highlighting a stable financial discipline and a shareholder-friendly policy.

Furthermore, the company's financial health is underlined by a robust balance sheet. UTMD holds more cash than debt, providing it with a strong liquidity position to navigate economic uncertainties. This is a reassuring sign for investors, particularly in an environment where many companies are grappling with high leverage.

InvestingPro Data paints a detailed picture of UTMD's financials. The company's market capitalization stands at 267.57 million USD, with a trailing twelve-month P/E ratio of 14.67, which is slightly lower than the current P/E ratio of 15.89. This indicates a reasonable valuation in the context of its earnings. Additionally, the company's gross profit margin for the last twelve months as of Q4 2023 is a healthy 59.81%, showing a strong ability to control costs and maintain profitability.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

For readers interested in a deeper analysis, there are additional InvestingPro Tips available for UTMD. These can provide further insights into the company's stock performance, valuation, and other financial metrics. To explore these tips and enhance your investment strategy, consider using the coupon code SFY24 to get an additional 10% off a 2-year InvestingPro+ subscription, or SFY241 to get an additional 10% off a 1-year InvestingPro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.